Simulating transmission scenarios of the Delta variant of SARS-CoV-2 in Australia

An outbreak of the Delta (B.1.617.2) variant of SARS-CoV-2 that began around mid-June 2021 in Sydney, Australia, quickly developed into a nation-wide epidemic. The ongoing epidemic is of major concern as the Delta variant is more infectious than previous variants that circulated in Australia in 2020. Using a re-calibrated agent-based model, we explored a feasible range of non-pharmaceutical interventions, including case isolation, home quarantine, school closures, and stay-at-home restrictions (i.e., "social distancing"). Our modelling indicated that the levels of reduced interactions in workplaces and across communities attained in Sydney and other parts of the nation were inadequate for controlling the outbreak. A counter-factual analysis suggested that if 70% of the population followed tight stay-at-home restrictions, then at least 45 days would have been needed for new daily cases to fall from their peak to below ten per day. Our model successfully predicted that, under a progressive vaccination rollout, if 40-50% of the Australian population follow stay-at-home restrictions, the incidence will peak by mid-October 2021. We also quantified an expected burden on the healthcare system and potential fatalities across Australia.

[1]  N. Geard,et al.  Risk mapping for COVID-19 outbreaks in Australia using mobility data , 2020, Journal of the Royal Society Interface.

[2]  E. Nsoesie,et al.  Sensitivity Analysis of an Individual-Based Model for Simulation of Influenza Epidemics , 2012, PloS one.

[3]  Mikhail Prokopenko,et al.  Interfering with influenza: nonlinear coupling of reactive and static mitigation strategies , 2020, Journal of the Royal Society Interface.

[4]  Oliver M. Cliff,et al.  Urbanization affects peak timing, prevalence, and bimodality of influenza pandemics in Australia: Results of a census-calibrated model , 2018, Science Advances.

[5]  Anne Kimball,et al.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.

[6]  Mikhail Prokopenko,et al.  Investigating Spatiotemporal Dynamics and Synchrony of Influenza Epidemics in Australia: An Agent-Based Modelling Approach , 2018, Simul. Model. Pract. Theory.

[7]  Mikhail Prokopenko,et al.  Creating a surrogate commuter network from Australian Bureau of Statistics census data , 2018, Scientific Data.

[8]  Alessandro Vespignani,et al.  Comparing large-scale computational approaches to epidemic modeling: Agent-based versus structured metapopulation models , 2010, BMC infectious diseases.

[9]  Ross J. Harris,et al.  Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis , 2021, BMJ.

[10]  Mikhail Prokopenko,et al.  Modelling transmission and control of the COVID-19 pandemic in Australia , 2020, Nature communications.

[11]  Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications , 2020, European Journal of Epidemiology.

[12]  Estimating the impact of control measures to prevent outbreaks of COVID-19 associated with air travel into a COVID-19-free country , 2021, Scientific reports.

[13]  C. C. Kerr,et al.  Modelling the impact of reducing control measures on the COVID-19 pandemic in a low transmission setting , 2020, medRxiv.

[14]  C. Macken,et al.  Mitigation strategies for pandemic influenza in the United States. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Mark Stevenson,et al.  The probability of the 6‐week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS‐CoV‐2 , 2020, The Medical journal of Australia.

[16]  Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.

[17]  M. van Boven,et al.  Controlling the pandemic during the SARS-CoV-2 vaccination rollout , 2021, Nature Communications.

[18]  J. Kaldor,et al.  Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic , 2020, The Medical journal of Australia.

[19]  World Health Organization,et al.  Calibrating Long-Term Non-Pharmaceutical Interventions for COVID-19: Principles and Facilitation Tools , 2020 .

[20]  C. Dalton,et al.  Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study , 2020, The Lancet Child & Adolescent Health.

[21]  P. Austin,et al.  Effectiveness of COVID-19 vaccines against variants of concern, Canada , 2021, medRxiv.

[22]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[23]  Joel C. Miller Spread of infectious disease through clustered populations , 2008, Journal of The Royal Society Interface.

[24]  Lucie Abeler-Dörner,et al.  Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing , 2020, Science.

[25]  J. Lopez Bernal,et al.  Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply. , 2021, The New England journal of medicine.

[26]  Hannah R. Meredith,et al.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.

[27]  C. Viboud,et al.  Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study , 2020, BMJ.

[28]  P. Vollmar,et al.  Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[29]  M. Prokopenko,et al.  Revealing COVID-19 Transmission by SARS-CoV-2 Genome Sequencing and Agent Based Modelling , 2020, bioRxiv.

[30]  A modelling analysis of the effectiveness of second wave COVID-19 response strategies in Australia , 2021, Scientific reports.

[31]  M. V. Van Kerkhove,et al.  Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[32]  L. Luo,et al.  Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2 — Guangdong Province, China, May–June 2021 , 2021, China CDC weekly.

[33]  N. Andrews,et al.  Effectiveness of COVID-19 vaccines against the B.1.617.2 variant , 2021, medRxiv.